PDF下载 ( 253 KB)
Advances in the pathogenesis of liver fibrosis
-
-
[1]Friedman SL.Cytokines and fibrogenesis[J].Semin Liver Dis, 1999, 19 (2) ∶129-140. [2]王萍.血小板衍生生长因子与肝纤维化[J].国外医学.消化疾病分册, 2000, 20 (1) ∶40-43. [3]Boesen CC, Radaev S, Motyka SA, et al.The 1.1 A crystal struc-ture of human TGF-beta type II receptor ligand bindingdomain[J].Structure, 2002, 10 (7) ∶913-919. [4]Schuster N, Krieglstein K.Mechanisms of TGF-beta-mediatedapoptosis[J].Cell Tissue Res, 2002, 307 (1) ∶1-14. [5]Palmer EM, Beilfuss BA, Nagai T, et al.Human helper Tcell acti-vation and differentiation is suppressed by porcine small intestinalsubmucosa[J].Tissue Eng, 2002, 8 (5) ∶893-900. [6]Hodge S, Hodge G, Flower R, et al.Up-regulation of productionof TGF-beta and IL-4 and down-regulation of IL-6 by apoptotichuman bronchial epithelial cells[J].Imnaunol Cell Biol, 2002, 80 (6) ∶537-543. [7]Paradis H, Liu CY, Saika S, et al.Tubedown-1 in remodeling ofthe developing vitreal vasculature in vivo and regulation of capillaryoutgrowth in vitro[J].Dev Biol, 2002, 249 (1) ∶140-155. [8]Gressner AM, Weiskirchen R.Modern pathogenetic concepts of liverfibrosis suggest stellate cells and TGF-beta as major players andtherapeutic targets[J].Cell Mol Med, 2006, 10 (1) ∶76-99. [9]ZHAO Jun-fang, LIU Cheng, LIU Cheng-hai.TGF-βintracellular signal transduction and Smads protein[J].Chinesejournal of pathophysiology, 2002, 18 (3) ∶321-325. [10]梁志清, 何振平.贮脂细胞TGF-β1受体反义基因转移及对细胞外基质合成的抑制作用[J].中华医学杂志, 1998, 78∶850-852. [11]Laping NJ, Grygielko E, Mathur A, et al.Inhibition of transforminggrowth factor (TGF) -beta1-induced extracellular matrix with anovel inhibitor of the TGF-beta type I receptor kinase activity:SB-431542[J].Mol Pharmacol, 2002, 62, (1) ∶58-64. [12]Robert A B, piek E, Bottinger EP, et al.Is Smad3 a major playerin signal transduction pathways leading to fibrogenesis[J]?Chest, 2001, 120 (1 Suppl) ∶43S-47S. [13]de Caestecker MP, Paks WT, Frank CJ, et al.Smad2 transducescommon signals from receptor serine-threonine and tyrosinekinases[J].Genes Dev, 1998, 12 (11) ∶1587-1592. [14]Moustakas A, Souchelnytskyi S, Heldin CH.Smad regulation inTGF-beta signal transduction[J].Journal of Cell Science, 2001, 114 (24) ∶4359-4369. [15]Correia JJ, Chacko B M, Lam S S, et al.Sedimentation studies re-veal a direct role of phosphorylation in Smad3:Smad4 homo-andhetero-trimerization[J].Biochem, 2001, 40 (5) ∶1473-1482. [16]Wiercinska E, Wickert L, Denecke B, et al.Id1 is a critical media-tor in TGF-beta-induced transdifferentiation of rat hepatic stellatecell[J].Hepatology, 2006, 43 (5) ∶1032-41. [17]LI Guang-ming, SHI Yi, LI Ding-guo, et al.Effect of small inter-fering DNA targeting connective tissue growth factor on the synthesisand secretion of extracellular matrix in hepatic stellate cells[J].Zhonghua Gan Zang Bing Za Zhi, 2004, 12 (9) 526-9. [18]Holmes A, Abraham DJ, Sa S, et al.CTGF and SMADs, mainte-nance of scleroderma phenotype is independent of SMADsignaling[J].J Biol Chem, 2001, 276 (14) ∶10594-10601. [19]彭小东, 戴立里.结缔组织生长因子与肝纤维化的研究进展[J].胃肠病学与肝病学杂志, 2005, 14 (4) ∶425-427. [20]Saxena N K, Titus MA, Ding X, et al.Leptin as a novel profibro-genic cytokine in hepatic stellate cells:mitogenesis and inhibition ofapoptosis mediated by extracellular regulated kinase (ErK) and Aktphosphory lation[J].FASEB J, 2004, 18 (13) ∶1612-1614. [21]Cao Q, Mak K M, Lieber C S, et al.Leptin enhances alpha1 (I) collagen gene expression in LX-2 human hepatic stellate cellsthrough JAK-mediated H2O2-dependent MAPK pathways[J].JCell Biochem, 2006, 97 (1) ∶188-197. [22]何生松, 黄化方.酒精性肝硬化患者体外单核细胞肿瘤坏死因子受体的表达[J].中华内科杂志, 1997, 36 (8) ∶526-528. [23]Rockey DC, Malter JJ, Jarnagn WR, et al.Inhibition of rat hepaticlipocyte activation in culture by interferon-gamma[J].Hepatology, 1992, 16 (3) ∶776-784. [24]Napoli T, Bioshop GA, Meaughan GW.luereased interhepatic mes-sager RNA expereaaion of interleukin 2, 6 and 8in humancirrhosia[J].Gastroenology, 1994, 107 (3) ∶789-798. [25]王润平, 刘成, 刘平.肝纤维化形成过程中肝星状细胞激活的旁分泌机制[J].中华肝脏病杂志, 1997, 5 (3) ∶184-186. [26]Kura Y, Ohsaw AM, Shirain, et al.Expression of angiotensinⅡtype1 recetor in human cirrhotic liver Its relation to fibrosis and potalhypertension[J].Hepatol Res, 2005, 32 (3) ∶107-116. [27]Yang L, Bataller R, Dulyx J, et al.Attenuated hepatic inflammationand fibrosis in angiotensin type 1 a receptor deficient mice[J].JHepatol, 2005, 43 (2) ∶317-323. [28]Knittel T, Mehde M, Grundmann A, et al.Expression of matrixmetalloproteinases and their inhibitors during hepatic tissue repair inthe rat[J〗.Histochem Cell Biol, 2000, 113 (6) ∶443-453. [29]Koulentaki M, Valatas V, Xidakis K, et al.Matrix metalloprotein-ases and their inhibitors in acute viral hepatitis[J].J Viral Hepat, 2002, 9 (3) ∶189-193. [30]Woessner JF Jr.MMPs and TIMPs-an historical perspective[J].Mol Biotechnol, 2002 (1) ∶33-49. [31]Rippe RA.Life or death:the fate of the hepatic stellate cell follow-ing hepatic injury[J].Hepatology, 1998, 27 (5) ∶1447-1448. -
本文二维码
计量
- 文章访问数: 3348
- HTML全文浏览量: 5
- PDF下载量: 979
- 被引次数: 0
下载:
